Abstract:Abstract: Although numerous studies have demonstrated the impact of microbiome manipulation on human health, research on the microbiome's influence on female health remains relatively limited despite substantial disease burden. In light of this, we present a selected review of clinical trials and preclinical studies targeting both the vaginal and gut microbiomes for the prevention or treatment of various gynecologic conditions. Specifically, we explore studies that leverage microbiota transplants, probiotics, prebiotics, diet modifications, and engineered microbial strains. A healthy vaginal microbiome for females of reproductive age consists of lactic acid-producing bacteria predominantly of the Lactobacillus genus, which serves as a protective barrier against pathogens and maintains a balanced ecosystem. The gut microbiota's production of short-chain fatty acids, metabolism of primary bile acids, and modulation of sex steroid levels have significant implications for the interplay between host and microbes throughout the body, ultimately impacting reproductive health. By harnessing interventions that modulate both the vaginal and gut microbiomes, it becomes possible to not only maintain homeostasis but also mitigate pathological conditions. While the field is still working toward making broad clinical recommendations, the current studies demonstrate that manipulating the microbiome holds great potential for addressing diverse gynecologic conditions. Lay summary: Manipulating the microbiome has recently entered popular culture, with various diets thought to aid the microbes that live within us. These microbes live in different locations of our body and accordingly help us digest food, modulate our immune system, and influence reproductive health. The role of the microbes living in and influencing the female reproductive tract remains understudied despite known roles in common conditions such as vulvovaginal candidiasis (affecting 75% of females in their lifetime), bacterial vaginosis (25% of females in their lifetime), cervical HPV infection (80% of females in their lifetime), endometriosis (6-10% of females of reproductive age), and polycystic ovary syndrome (10-12% of females of reproductive age). Here, we review four different approaches used to manipulate the female reproductive tract and gastrointestinal system microbiomes: microbiota transplants, probiotics, prebiotics, and dietary interventions, and the use of engineered microbial strains. In doing so, we aim to stimulate discussion on new ways to understand and treat female reproductive health conditions.

The promising biological role of postbiotics derived from probiotic Lactobacillus species in reproductive health

The Role of Microbiomes in Pregnant Women and Offspring: Research Progress of Recent Years

Postbiotics as the new frontier in food and pharmaceutical research

Microorganisms in the reproductive system and probiotic's regulatory effects on reproductive health

Lactation-dependent Vertical Transmission of Natural Probiotics from the Mother to the Infant Gut Through Breast Milk.

Probiotics and the envisaged role in treating human infertility

Potential in vivo delivery routes of postbiotics

Effect of Postbiotics Derived from Lactobacillus rhamnosus PB01 (DSM 14870) on Sperm Quality: A Prospective In Vitro Study

The Use of Probiotics for Management and Improvement of Reproductive Eubiosis and Function

Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond

Promising bioactivities of postbiotics: A comprehensive review

Linking reproductive tract microbiota to premature ovarian insufficiency: Pathophysiological mechanisms and therapies

Pilot Study on Next-Generation Sequencing Analysis of Vaginal Microbiota in Clinically Infertile Patients Treated with Probiotics

Impact of Probiotics and Prebiotics on Gut Microbiome and Hormonal Regulation

Probiotic Lactobacillus rhamnosus species: considerations for female reproduction and offspring health

Biologia Futura: endometrial microbiome affects endometrial receptivity from the perspective of the endometrial immune microenvironment

Harnessing the power within: engineering the microbiome for enhanced gynecologic health

Pharmabiotic/phytobiotic formulas approach and their intravaginal effect on different parameters

The microbial revolution: Unveiling the benefits of vaginal probiotics and prebiotics

Postbiotics as Dynamic Biological Molecules for Antimicrobial Activity: A Mini-Review

Postbiotics as Metabolites and Their Biotherapeutic Potential